π΅οΈ Oncolytics Biotech Inc ($ONCY)
SEC insider & ownership activity, last 12 months Β· CIK 1129928 Β· every row links its SEC filing
Over the last 12 months insiders bought $363K with no open-market selling against it. Bernd R. Seizinger bought $187K in discretionary trades (JanβFeb). One red-flag 8-K in the window: Delisting notice (3.01), Jul 20, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
10 buyers, $363K (14 lots) Β· 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Bernd R. Seizinger | 3 | $187K | 0 | β | Feb 12, 2026 |
| Kelly Jared | 3 | $34K | 0 | β | Mar 12, 2026 |
| Patricia S. Andrews | 1 | $30K | 0 | β | Feb 12, 2026 |
| Aromando Andrew | 1 | $25K | 0 | β | Feb 11, 2026 |
| Pisano Wayne | 1 | $25K | 0 | β | Feb 12, 2026 |
| Brown Deborah Margaret | 1 | $21K | 0 | β | Feb 12, 2026 |
| James T. Parsons | 1 | $10K | 0 | β | Mar 11, 2026 |
| Look Kirk | 1 | $10K | 0 | β | Feb 12, 2026 |
| Heineman Thomas Charles | 1 | $10K | 0 | β | Feb 12, 2026 |
| Hagerman Allison | 1 | $8K | 0 | β | Feb 12, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Anson Funds Management LP | 7.0% | 13G | Nov 14, 2025 | filing β | |
| Anson Management GP LLC | 7.0% | 13G | Nov 14, 2025 | filing β | |
| Tony Moore | 7.0% | 13G | Nov 14, 2025 | filing β | |
| Anson Advisors Inc. | 7.0% | 13G | Nov 14, 2025 | filing β | |
| Amin Nathoo | 7.0% | 13G | Nov 14, 2025 | filing β | |
| Moez Kassam | 7.0% | 13G | Nov 14, 2025 | filing β |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Delisting notice (3.01) | Jul 20, 2026 | filing β |
| Other events (8.01) | Jul 20, 2026 | filing β |
| Other events (8.01) | Jul 13, 2026 | filing β |
| Auditor change (4.01) | Jul 6, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jul 6, 2026 | filing β |
| Other events (8.01) | Jun 16, 2026 | filing β |
| Officer/director changes (5.02) | Jun 2, 2026 | filing β |
| Other events (8.01) | Jun 2, 2026 | filing β |
| Other events (8.01) | Jun 1, 2026 | filing β |
| Other events (8.01) | May 22, 2026 | filing β |
| Other events (8.01) | May 4, 2026 | filing β |
| Other events (8.01) | Apr 27, 2026 | filing β |
| Other events (8.01) | Apr 6, 2026 | filing β |
| Other events (8.01) | Apr 6, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Apr 6, 2026 | filing β |
| Material agreement (1.01) | Mar 31, 2026 | filing β |
| Material Modifications to Rights of Security Holders (3.03) | Mar 31, 2026 | filing β |
| Officer/director changes (5.02) | Mar 31, 2026 | filing β |
| Charter/bylaw changes (5.03) | Mar 31, 2026 | filing β |
| Other events (8.01) | Mar 31, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing β |
| Other events (8.01) | Mar 19, 2026 | filing β |
| Material Modifications to Rights of Security Holders (3.03) | Mar 17, 2026 | filing β |
| Charter/bylaw changes (5.03) | Mar 17, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing β |
| Other events (8.01) | Mar 2, 2026 | filing β |
| Other events (8.01) | Feb 24, 2026 | filing β |
| Other events (8.01) | Feb 4, 2026 | filing β |
| Shareholder vote (5.07) | Jan 15, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jan 15, 2026 | filing β |